Tag: birthControlPills
Articles
- BRCA1 and BRCA2 mutation carriers
- How can we protect our daughters from breast cancer? - Teenage years and young adulthood
- How can young breast cancer survivors avoid a recurrence?
- How does birth control pill use influence breast cancer risk?
- Latest research concerning breast cancer in Asian Americans
- Triple negative breast cancer
News
- Apigenin may prevent breast cancer that develops in response to progestin
- Birth control pills with levonorgestrel as the progestin increase risk of breast cancer
- Estrogen in chicken and beef may be contributing to hormone-dependent cancers
- High circulating estrogen and androgen increase risk of postmenopausal breast cancer
- Loss of spouse does not increase risk of breast cancer recurrence
- Mexican breast cancer patients are younger and more likely to have triple negative breast cancer
- Not giving birth reduces risk of triple negative breast cancer
- Oral contraceptive use at young age increases risk of triple negative breast cancer
- Oral contraceptive use increases risk of ER-/PR- breast cancer among African-Americans
- Three cases of inflammatory breast cancer in one office suggest environmental causes
Studies
- A Case-Control Study of Oral Contraceptive Use and Incident Breast Cancer
- A cluster of inflammatory breast cancer (IBC) in an office setting: additional evidence of the importance of environmental factors in IBC etiology
- Age and Menopausal Effects of Hormonal Birth Control and Hormone Replacement Therapy in Relation to Breast Cancer Risk
- Association of Hormone-Related Characteristics and Breast Cancer Risk by Estrogen Receptor/Progesterone Receptor Status in the Shanghai Breast Cancer Study
- BRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50
- Correlation of Age at Oral Contraceptive Pill Start with Age at Breast Cancer Diagnosis
- Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20-44 years of age
- Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the Cyclin D1/MYC promoters
- Extra-tumoral breast tissue in breast cancer patients: Variations with steroid contraceptive use
- Hormone therapy and risk for breast cancer in Finnish postmenopausal women
- Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing
- Injectable and Oral Contraceptive Use and Cancers of the Breast, Cervix, Ovary, and Endometrium in Black South African Women: Case-Control Study
- Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer
- Mammographic Density, Response to Hormones, and Breast Cancer Risk
- Meta-analysis of the risk factors of breast cancer concerning reproductive factors and oral contraceptive use
- Oral contraceptive formulation and risk of breast cancer
- Oral Contraceptive Use and Breast Cancer: A Prospective Study of Young Women
- Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis
- Oral Contraceptive Use and Estrogen/Progesterone Receptor-Negative Breast Cancer among African American Women
- Oral Contraceptive Use and Parity Associations with Uncommon Breast Cancer Histologies in the Breast Cancer Family Registry: the Role of Family History
- Oral contraceptive use and survival in women with invasive breast cancer
- Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis
- Oral, injected and implanted contraceptives and breast cancer risk among U.S. Hispanic and non-Hispanic white women
- Relationship between oral contraceptive therapy and estrogen receptor status in patients with breast cancer
- Relationship Between Use of Different Oral Contraceptive Formulations and Breast Cancer Risk Among Young Women
- Reproductive factors, exogenous female hormone use and breast cancer risk in Japanese: the Miyagi Cohort Study
- Reproductive History and Oral Contraceptive Use in Relation to Risk of Triple-Negative Breast Cancer
- Risk Factors for Breast Cancer for Women Aged 40 to 49 Years
- Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years
- Triple-negative breast cancer in Hispanic patients
- Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study
- Use of the levonorgestrel-releasing intrauterine system in breast cancer patients
- ZEN and the art of breast health maintenance